This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_SKIN_LIP_EXALLC for full statistics.
Carcinoma in situ of skin of lip
CD2_INSITU_SKIN_LIP
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
97 |
4. Check minimum number of eventsNone |
97 |
5. Include endpointsNone |
97 |
6. Filter based on genotype QC (FinnGen only) |
97 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis labii (oris)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of lip
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of lip
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 97 | 38 | 59 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 73.30 | 73.96 | 72.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 88
- Matched controls
- 880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
+∞
126.7
88
*
L57.0
ICD-10 Finland
Actinic keratosis
21.7
34.4
59
75
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
18.3
29.6
52
64
TQW99
NOMESCO Finland
Other minor procedure on skin
28.4
29.3
41
26
EAA10
NOMESCO Finland
Excision of lesion of lip
181.4
26.2
26
*
ZXC20
NOMESCO Finland
Use of chemical agents
31.7
20.6
27
12
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
43.6
19.1
23
7
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
22.3
18.5
27
17
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
+∞
18.4
17
*
ZQZ00
NOMESCO Finland
Treatment of several skin areas
222.8
18.2
18
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.9
17.4
39
65
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
18.8
16.9
26
19
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
22.4
14.7
21
12
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
51.7
14.7
17
*
Z2221
NOMESCO Finland
Medical doctor
6.0
13.6
50
158
ZXC10
NOMESCO Finland
Use of laser
44.5
12.7
15
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
9.5
12.2
26
37
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
75.2
11.9
13
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
20.6
11.7
17
10
ZZR00
NOMESCO Finland
Flap of skin
17.0
11.6
18
13
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
7.0
11.6
31
63
EAA30
NOMESCO Finland
Partial excision of lower lip
50.2
11.3
13
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
14.7
10.9
18
15
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.6
10.6
35
92
R4110
NOMESCO Finland
Physiotherapy
4.8
10.4
44
151
ZXD10
NOMESCO Finland
Scheduled procedure
4.5
10.4
55
236
D06BB10
ATC
imiquimod; topical
10.7
9.9
19
22
WX002
NOMESCO Finland
Sedation and analgesia
5.1
9.5
34
96
Z3231
NOMESCO Finland
Registered nurse
4.1
9.0
47
191
XF400
NOMESCO Finland
ECG with 12 standard connections
4.7
8.9
35
109
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.8
8.6
22
41
D07AB08
ATC
desonide; topical
6.7
8.2
21
39
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
49.5
7.9
9
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.7
7.5
27
75
Z3226
NOMESCO Finland
Physiotherapist
4.1
7.4
32
107
ZXA05
NOMESCO Finland
Left side
3.6
7.0
41
173
ZXE00
NOMESCO Finland
One hour or less
3.3
6.6
48
236
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
40
88
7.03
19.17
2.6
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
70
271
6.69
17.83
5.2
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
21
10.30
14.62
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
136
4.68
12.32
3.6
2.8
e6/l
0.6
1.2
0.83
25
83
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
134
4.38
11.06
3.7
3.0
e6/l
2.7
1.5
0.24
23
82
(3000991) Gas panel - Venous blood
24
64
4.65
8.71
7.0
7.2
—
—
—
0
0
(4035726)
22
64
4.15
7.06
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
55
290
3.07
6.86
5.1
4.0
e6/l
51.8
74.9
0.29
40
219
(36304419) Bacteria [Presence] in Urine
45
214
3.06
6.71
4.7
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
47
235
2.94
6.33
4.6
3.2
e6/l
0.7
0.3
0.61
36
180
(3002582) Erythrocytes [#/volume] in Urine
50
262
2.87
6.13
4.6
3.3
e6/l
132.6
334.5
0.37
40
208
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
152
3.04
6.02
2.2
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
53
293
2.78
5.77
4.7
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
38
184
2.75
5.26
8.7
7.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
23
85
3.24
5.12
5.4
3.8
kpa
5.7
5.7
0.02
23
80
(3012544) pH of Venous blood
23
88
3.12
4.82
5.3
3.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
15
44
3.85
4.68
2.7
2.1
g/l
1.8
1.7
0.17
15
39
(3000494) Fungus identified in Specimen by Culture
22
84
3.09
4.62
1.6
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
104
2.89
4.52
2.2
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
80
588
3.06
4.44
35.4
19.3
%
39.1
38.3
0.52
63
359
(3002385) Erythrocyte distribution width [Ratio]
77
555
2.88
4.44
36.8
22.1
%
14.2
14.0
0.47
77
537
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
100
2.86
4.31
2.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
20
76
3.06
4.22
2.3
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
19
72
3.04
4.02
2.7
3.2
kpa
4.9
4.2
0.52
19
67
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
55
3.29
3.95
1.5
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
70
505
2.39
3.63
5.1
4.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
53
3.16
3.54
1.8
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
18
71
2.89
3.54
7.7
5.5
mmol/l
13.0
11.1
0.50
18
66
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
184
2.31
3.52
3.1
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
53
345
2.18
3.49
2.9
2.2
pmol/l
92.4
93.2
0.04
28
174
(3024561) Albumin [Mass/volume] in Serum or Plasma
55
365
2.17
3.43
5.4
3.8
g/l
34.4
34.6
0.08
49
336
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
49
313
2.14
3.34
2.2
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
26
128
2.41
3.31
2.4
2.7
mmol/l
0.8
0.8
0.83
26
118
(3024928) Oxygen saturation in Venous blood
8
15
5.70
3.26
2.1
2.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
11
6.76
3.24
2.0
1.8
%
60.1
65.0
—
7
11
(3001604) Monocytes [#/volume] in Blood
53
356
2.08
3.10
8.5
5.4
e9/l
0.6
0.6
0.08
45
306
(3006315) Basophils [#/volume] in Blood
53
357
2.07
3.07
8.5
5.4
e9/l
0.0
0.0
0.21
44
309
(3022948) Iron [Moles/volume] in Serum or Plasma
28
147
2.27
3.07
3.9
2.2
umol/l
11.5
12.6
0.38
28
132
(42870588) Differential panel, method unspecified - Blood
41
251
2.10
3.07
7.5
4.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
5
10.44
3.01
1.8
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
69
518
2.15
2.92
5.2
4.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
18
79
2.57
2.89
1.2
2.4
e9/l
73.7
67.3
—
7
66
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
18
4.74
2.86
1.3
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
53
365
2.00
2.81
8.7
5.7
e9/l
0.1
0.2
1.32
45
320
(3019198) Lymphocytes [#/volume] in Blood
53
366
1.99
2.78
8.8
5.5
e9/l
1.9
1.9
0.02
45
321
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
38
3.14
2.68
1.6
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
47
315
1.95
2.65
11.4
10.7
e9/l
0.0
0.0
0.38
40
266
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
83
2.43
2.61
1.8
3.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
57
2.70
2.58
1.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
39
3.05
2.57
1.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
39
3.05
2.57
2.3
2.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
18
85
2.37
2.48
3.1
2.5
umol/l
6.4
12.5
1.40
18
75
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
35
216
1.97
2.47
3.1
2.1
mg/l
3.1
3.0
0.08
30
191
(3012516) Albumin [Mass/volume] in Urine
37
233
1.95
2.47
4.5
3.1
mg/l
109.8
58.8
0.28
25
159
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
46
2.84
2.46
7.4
6.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
22
114
2.20
2.45
6.1
5.5
mmol/l
1.2
1.4
0.05
16
88
(3042936) Bacteria identified in Isolate by Culture
21
107
2.23
2.44
1.9
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
38
244
1.92
2.38
3.4
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
48
333
1.87
2.37
4.7
3.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
80
663
2.18
2.25
27.9
16.5
ml/min/173m2
65.4
71.2
1.34
64
557
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
43
2.76
2.18
1.3
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
56
416
1.82
2.16
12.3
8.6
e9/l
4.7
4.5
0.24
50
364
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
22
357
0.50
2.11
4.4
4.2
ng/l
25.1
52.8
1.39
17
285
(3034860) Kappa light chains.free [Mass/volume] in Serum
9
32
2.99
2.06
1.1
3.3
mg/l
72.4
250.8
—
9
26
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
9
32
2.99
2.06
1.1
3.3
mg/l
52.5
26.0
—
9
26
(3020564) Creatinine [Moles/volume] in Serum or Plasma
86
742
2.40
2.05
31.3
20.6
umol/l
100.7
86.2
1.18
86
742
(36660697) Celiac disease serology panel - Serum
10
39
2.74
1.99
1.0
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
25
149
1.91
1.91
2.2
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
32
211
1.77
1.77
3.5
2.7
umol/l
14656.5
9485.3
0.14
26
171
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
55
2.35
1.76
1.3
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
42
2.54
1.74
1.3
6.5
mmol/l
26.8
24.5
—
10
42
(3009445) Proteinase 3 Ab [Units/volume] in Serum
8
31
2.72
1.70
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
43
2.48
1.66
2.4
2.8
%
1.0
1.1
—
10
43
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
26
2.82
1.61
1.3
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
26
2.82
1.61
1.3
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
44
2.42
1.59
1.1
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
44
2.42
1.59
1.1
1.5
g/l
10.1
10.7
—
10
39
(3020682) Albumin/Creatinine [Ratio] in Urine
36
253
1.67
1.57
5.3
3.8
mg/mmol
24.4
9.5
0.41
23
167
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
15
3.45
1.54
3.0
3.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
85
753
2.04
1.51
31.7
20.2
mmol/l
138.7
139.6
2.06
85
728
(3023103) Potassium [Moles/volume] in Serum or Plasma
85
754
2.03
1.49
32.5
20.2
mmol/l
4.0
4.0
0.51
85
729
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
22
2.84
1.46
3.0
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
70
590
1.67
1.43
9.3
7.1
u/l
74.3
81.0
0.99
65
548
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
41
2.31
1.41
1.1
1.6
g/l
3.8
3.1
—
9
36
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
41
2.31
1.41
1.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
36
260
1.61
1.39
4.1
3.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
38
0.00
1.38
0.0
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
39
0.00
1.37
0.0
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
36
262
1.59
1.34
6.1
4.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
24
2.60
1.32
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
24
2.60
1.32
1.3
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
81
716
1.80
1.31
25.6
17.1
mg/l
33.4
27.3
0.71
65
593
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
18
2.87
1.30
1.0
1.1
—
—
—
0
0
(3013512) EKG study
17
264
0.57
1.29
4.4
4.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
19
2.72
1.23
1.8
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
85
768
1.86
1.19
39.3
25.0
g/l
128.4
132.2
1.37
85
747
(3024731) MCV [Entitic volume]
85
768
1.86
1.19
39.0
24.8
fl
92.1
91.9
0.13
85
748
(3035941) MCH [Entitic mass]
85
768
1.86
1.19
38.9
24.7
pg
30.5
30.5
0.00
85
748
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
20
2.58
1.16
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
20
2.58
1.16
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
20
2.58
1.16
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
25
172
1.61
1.15
1.4
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
8
41
2.03
1.11
3.4
1.7
g/l
8.1
10.3
—
8
35
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
22
2.34
1.04
2.2
2.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
82
742
1.68
1.03
15.3
10.9
u/l
21.5
23.3
0.90
82
706
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
35
2.08
1.02
3.3
2.9
pmol/l
4.0
4.4
—
7
30
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
29
213
1.52
1.01
3.3
3.0
u/l
32.9
31.5
0.10
29
201
(3049717) Cytology report of Urine Cyto stain
7
37
1.96
0.96
1.7
3.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
27
2.30
0.95
1.2
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
56
1.88
0.91
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
31
2.00
0.86
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
17
116
1.56
0.81
1.6
1.3
g/l
2.5
2.6
—
5
62
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
39
1.86
0.74
3.0
3.4
u/ml
9.4
981.4
—
7
34
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
210
1.40
0.69
5.0
3.3
ug/l
0.6
0.8
0.41
19
144
(3052851) Hemolysis interference index of Serum or Plasma
5
29
1.76
0.64
4.0
3.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14
194
0.67
0.63
1.4
1.8
pmol/l
459.6
476.6
—
9
168
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
30
1.70
0.62
1.8
2.4
mmol/l
22.8
24.9
—
5
21
(1761868) Lipid panel - Serum or Plasma
15
204
0.69
0.61
5.4
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
78
727
1.37
0.54
19.1
16.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
54
480
1.28
0.54
5.6
4.3
mmol/l
6.9
7.0
0.10
54
453
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
65
1.42
0.52
1.1
1.6
nmol/l
471.1
409.3
—
9
60
(3000330) Specific gravity of Urine by Test strip
7
45
1.60
0.50
4.0
5.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
91
0.64
0.45
15.0
9.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
70
1.48
0.43
6.2
3.6
—
—
—
0
0
(3000492) Spirometry study
8
59
1.39
0.42
1.3
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
33
1.54
0.42
1.0
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
0.3
—
0
15
(4094501)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
1.3
—
0
16
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
16
199
0.77
0.38
3.7
4.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
70
1.31
0.38
1.1
2.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
100
1.35
0.36
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
54
1.32
0.31
2.1
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
139
0.76
0.29
7.4
5.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
271
0.85
0.24
3.8
4.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
32
290
1.15
0.22
8.4
4.4
%
21.8
21.1
0.11
13
149
(3039443) Prostate specific Ag panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.5
—
49.8
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
6
51
1.19
0.20
2.5
2.9
e6/l
0.0
0.1
—
6
51
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
60
0.82
0.08
4.0
2.6
kpa
4.9
5.1
—
5
52
(4010399)
5
62
0.80
0.08
1.8
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
63
0.78
0.08
4.4
3.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
84
1.08
0.07
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
10
93
1.08
0.02
3.1
2.7
ug/l
12.1
6.1
—
10
80
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.8
—
1.8
—
0
9
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
0.00
0.0
2.2
—
65.2
—
0
9
(3004616) Nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
9
0.00
0.00
0.0
2.2
—
5.4
—
0
9
(3038026) Centromere Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
319.0
—
0
5
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
2390.0
—
0
5
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
7
0.00
0.00
0.0
1.1
—
2.1
—
0
7
(3009343) pH of Capillary blood
5
57
0.87
0.00
4.0
2.6
—
7.4
—
0
8
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
50
1.00
0.00
2.4
1.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
8.8
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
21.4
—
0
6
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
2.2
—
32.0
—
0
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_LIP – Carcinoma in situ of skin of lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).